Acer Therapeutics Inc. ACER
0.66 +0.66
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2022 · select a line to chart its full history
Income statement
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| -24.61M | -15.95M | -22.80M | -29.90M | -21.71M | |
| -26.24M | -15.37M | -22.89M | -29.42M | -21.28M | |
| -1.66 | -1.08 | -2.06 | -2.91 | -2.49 |
Balance sheet
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 2.33M | 12.71M | 5.76M | 12.08M | 41.67M | |
| 11.62M | 36.26M | 14.61M | 21.47M | 50.66M | |
| 28.39M | 37.98M | 6.39M | 3.10M | 5.58M | |
| 11.61M | 0 | 0 | 0 | 0 | |
| -16.76M | -1.72M | 8.22M | 18.37M | 45.08M |
Cash flow
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| -30.25M | -134.91K | -17.03M | -29.51M | -16.59M | |
| -171.17K | -54.94K | -10.90K | -178.97K | -95.63K | |
| 20.04M | 7.14M | 10.72M | 92.27K | 42.71M | |
| -171.17K | -54.94K | -10.90K | -178.97K | -95.63K | |
| -10.38M | 6.95M | -6.32M | -29.59M | 26.03M |